Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised for their value.
What happens in the world of Facebook cannot be ignored in pharma marketing. It increasingly lives in a world of data that is highly sensitive and must be managed well.
A study by Cohn & Wolfe cited that 63% of consumers would choose a company they believe to be authentic over its competitors.
Technology like this could expand further to form better collaborations between pharma, payers and organized providers.